Business Context and Reporting Period
This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) was submitted on February 18, 2005. The report addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and contains no financial data.
Material Changes
The material change disclosed is the departure of Dr. Regina Herzlinger from the Board of Directors. Dr. Herzlinger, who was nominated for re-election, informed the Company on February 18, 2005, of her decision not to stand for re-election at the annual meeting scheduled for May 2, 2005.
Management Commentary and Risks
Management stated that Dr. Herzlinger's decision was not the result of any disagreement with the Company regarding its operations, policies, or practices. She will continue to serve the remainder of her current term. No other risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investors
- Dr. Regina Herzlinger will not seek re-election as a director at the May 2, 2005 annual meeting.
- The departure is voluntary and unrelated to any disagreement with company management or policy.
- Dr. Herzlinger remains a director until the conclusion of her current term.
- No financial performance data is included in this specific filing.